Research Paper
Xiaoyun Gao and John Cai Lin
Abstract
Objective: To explore the effect of sclerosing agent local injection therapy in infantile hemangioma, Pyogenic granuloma, lymphatic malformation and venous malformation. Methods: 1000 patients with vascular abnormalities were treated with sclerosing agent injection, followed up for observation, and evaluated to determine the efficacy. Results: The follow-up time was 2 months to 5 years. The total effective rate of all kinds of vascular abnormalities was 96.5%. The cure rate of lymphatic malformation was 100%, the cure rate of Pyogenic granuloma was 100%, the cure rate of infantile hemangioma was 98%, and the venous malformations cure rate stood at 90%. Conclusion: Sclerotherapy can be used as the first choice treatment option for infantile hemangioma, Pyogenic granuloma, lymphatic malformation and venous malformation.